Diabetes and thrombolysis for acute stroke: A clear benefit for diabetics

European Journal of Neurology

Volumn 21, Issue 1, 2014, Pages 5-10

  Reiter, M ^a,b   Teuschl, Y ^a   Matz, K ^a,b   Seyfang, L ^a   Brainin, M ^a,b  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b Department of Neurology Danube Clinic Tulln   (Austria)

Author keywords

Diabetes; Intravenous thrombolysis; Stroke

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DISABILITY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FUNCTIONAL STATUS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; STROKE PATIENT; STROKE UNIT;

DIABETES; INTRAVENOUS THROMBOLYSIS; STROKE;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HUMANS; MALE; REGISTRIES; STROKE; THROMBOLYTIC THERAPY;

EID: 84890124927     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12263     Document Type: Article

References (23)

1. Ahmed N, Dávalos A, Eriksson N, et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). Arch Neurol 2010; 67: 1123-1130.
2. Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 2009; 32: 617-622.
3. Lansberg MG, Albers GW, Wijman CAC. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007; 24: 1-10.
4. Committee for Proprietary Medicinal Products for the European Agency for the Evaluation of Medicinal Products. Summary information on a referral opinion following an arbitration pursuant to article 29 of directive 2001/83/EC for Actilyse. 2002. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Actilyse_29/WC500010327.pdf. (accessed 27/03/2013)
5. Mishra NK, Ahmed N, Davalos A, et al. Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology 2011; 77: 1866-1872.
6. Fuentes B, Martínez-Sánchez P, Alonso de Leciñana M, et al. Diabetes and previous stroke: hazards for intravenous thrombolysis? Eur J Neurol 2012; 19: 587-593.
7. Bluhmki E, Chamorro A, Dávalos A, et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol 2009; 8: 1095-1102.
8. Reiner-Deitemyer V, Teuschl Y, Matz K, et al. Helicopter transport of stroke patients and its influence on thrombolysis rates: data from the Austrian Stroke Unit Registry. Stroke 2011; 42: 1295-1300.
9. Ferrari J, Knoflach M, Kiechl S, et al. Early clinical worsening in patients with TIA or minor stroke: the Austrian Stroke Unit Registry. Neurology 2010; 74: 136-141.
10. World Health Organization Department of Noncommunicable Disease Surveillance. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99.2 ed. Geneva: World Health Organization, 1999.
11. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus, Abbreviated Report of a WHO Consultation.2011. http://www.who.int/diabetes/publications/report-hba1c_2011.pdf (accessed 23/05/2013).
12. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Consensus paper. Cerebrovasc Dis 2008; 25: 457-507.
13. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
14. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-1526.
15. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
16. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4, 5 h after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
17. Ahmed N, Wahlgren N, Grond M, et al. Implementation and outcome of thrombolysis with alteplase 3-4, 5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol 2010; 9: 866-874.
18. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, 2010. http://www.R-project.org. (accessed 27/03/2013).
19. Sekhon JS. Multivariate and propensity score matching software with automated balance optimization: the matching package for R. J Stat Softw 2011; 42: 1-52.
20. De Keyser J, Gdovinová Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke 2007; 38: 2612-2618.
21. Ribo M, Molina C, Montaner J, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 2005; 36: 1705-1709.
22. Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab 2007; 27: 435-451.
23. Gensicke H, Seiffge DJ, Polasek AE, et al. Long-term outcome in stroke patients treated with IV thrombolysis. Neurology 2013; 80: 919-925.